Cargando…

ESMO - Magnitude of Clinical Benefit Scale V.1.0 questions and answers

The ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) is a standardised, generic, validated tool to stratify the magnitude of clinical benefit that can be anticipated from anticancer therapies. The ESMO-MCBS is intended to both assist oncologists in explaining the likely benefits of a particular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cherny, N I, Sullivan, R, Dafni, U, Kerst, J M, Sobrero, A, Zielinski, C, Piccart, M J, Bogaerts, J, Tabernero, J, Latino, N J, de Vries, E G E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115817/ https://www.ncbi.nlm.nih.gov/pubmed/27900206 http://dx.doi.org/10.1136/esmoopen-2016-000100

Ejemplares similares

Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules
por: Dafni, Urania, et al.
Publicado: (2017)

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring
por: Gyawali, B., et al.
Publicado: (2021)

Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapies
por: Paluch-Shimon, Shani, et al.
Publicado: (2020)

PB2707: ESMO-MAGNITUDE OF CLINICAL BENEFIT SCALE FOR HAEMATOLOGICAL MALIGNANCIES (ESMO-MCBS:H) VERSION 1.0
por: Kiesewetter, Barbara, et al.
Publicado: (2023)

EHA evaluation of the ESMO—Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for haematological malignancies
por: Kiesewetter, Barbara, et al.
Publicado: (2020)

Applying the ESMO-Magnitude of Clinical Benefit Scale in real life
por: Ciardiello, Fortunato, et al.
Publicado: (2016)

Lessons learnt from scoring adjuvant colon cancer trials and meta-analyses using the ESMO-Magnitude of Clinical Benefit Scale V.1.1
por: Knapen, Daan Geert, et al.
Publicado: (2020)

“The first ones now, will later be last”: understanding the importance of historical context when reading ESMO-MCBS scores
por: Cherny, N.I., et al.
Publicado: (2022)

Evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for adjuvant radiotherapy in breast cancer
por: Sapir, E., et al.
Publicado: (2023)

Implementation of the ESMO-Magnitude of Clinical Benefit Scale: real world example from the 2022 Israeli National Reimbursement Process
por: Wolf, I., et al.
Publicado: (2022)

ESMO-Magnitude of Clinical Benefit Scale (MCBS) group
por: Amaral, Teresa
Publicado: (2019)

Prioritising systemic cancer therapies applying ESMO’s tools and other resources to assist in improving cancer care globally: the Kazakh experience
por: Latino, N.J., et al.
Publicado: (2022)

The hard road to ranking the clinical benefit of antineoplastic agents: ESMO Award 2016 presentation
por: Sobrero, Alberto
Publicado: (2017)

Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) version 1.1
por: Pichler, M., et al.
Publicado: (2021)

Essential cancer medicines: adding feasibility to the magnitude of clinical benefit value chain
por: Roitberg, F., et al.
Publicado: (2023)

Indicators of integration at ESMO Designated Centres of Integrated Oncology and Palliative Care
por: Hui, David, et al.
Publicado: (2018)

ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe
por: Cherny, N I, et al.
Publicado: (2017)

ESMO gave me a chance to help make a difference: a personal reflection on the occasion of receiving the 2015 ESMO Award
por: Cherny, Nathan I
Publicado: (2016)

ESMO pays tribute to Professor José Baselga
por: Peters, S., et al.
Publicado: (2021)

ESMO pays tribute to Professor José Baselga
por: Peters, S., et al.
Publicado: (2021)

ESMO Designated Centres of Integrated Oncology and Palliative Care (ESMO DCs): education, research and programme development survey
por: Kreye, G., et al.
Publicado: (2022)

FCC-ee: Your Questions Answered
por: Blondel, A., et al.
Publicado: (2019)

Corrigendum to ‘Remembering Professor José Baselga’: [ESMO Open Volume 6, Issue 3, June 2021, 100121]
por: Tabernero, J.
Publicado: (2021)

ESMO and WHO: 14 years of working in partnership on cancer control
por: Ullrich, Andreas, et al.
Publicado: (2016)

Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO)
por: Morgan, Gilberto, et al.
Publicado: (2016)

Questions & Answers
por: CERN. Geneva
Publicado: (2019)

Questions and answers
por: Jones, Rhodri, et al.
Publicado: (2023)

Questions and answers
por: Jones, Rhodri, et al.
Publicado: (2022)

Questions and Answers
Publicado: (1887)

The Question Answered
por: Smith, C. Carleton
Publicado: (1881)

Questions and Answers
Publicado: (1895)

Questions and answers on power electronics
por: Bandyopadhyay, M N
Publicado: (2020)

ESMO Open—Cancer Horizons and the future of oncology
por: Zielinski, Christoph C
Publicado: (2016)

AIOM chooses ESMO Open—Cancer Horizons as its official journal: a warm welcome from ESMO Open
por: Zielinski, Christoph C, et al.
Publicado: (2016)

Are Quality of Randomized Clinical Trials and ESMO-Magnitude of Clinical Benefit Scale Two Sides of the Same Coin, to Grade Recommendations for Drug Approval?
por: Rodriguez, Adela, et al.
Publicado: (2021)

COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE)
por: Castelo-Branco, L., et al.
Publicado: (2022)

CSCO joins ESMO Open—Cancer Horizons
por: Zielinski, Christoph C, et al.
Publicado: (2016)

Automatic question answering for multiple stakeholders, the epidemic question answering dataset
por: Goodwin, Travis R., et al.
Publicado: (2022)

A pamphlet to answer patients' questions
por: Steele, S.J., et al.
Publicado: (1975)

Female leadership in oncology—has progress stalled? Data from the ESMO W4O authorship and monitoring studies
por: Berghoff, A.S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_94s8gtd92a80rm9a1dtddjbdga